Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MPG.0000000000003005 http://scihub22266oqcxt.onion/10.1097/MPG.0000000000003005 33306581!7984630!33306581     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33306581&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Pediatr+Gastroenterol+Nutr 2021 ; 72 (4): 511-513 Nephropedia Template TP {{tp|p=33306581|t=2021. The Effect of Helicobacter pylori on the Presentation and Clinical Course of Coronavirus Disease 2019 Infection |pdf=|usr=}}{{33306581}} gab.com Text The Effect of Helicobacter pylori on the Presentation and Clinical Course of Coronavirus Disease 2019 Infection JO: J Pediatr Gastroenterol Nutr http://www.kidney.de/pget.php?&tw=1&pmid=33306581 #FOAvip OBJECTIVES: Novel coronavirus 2019 (corona virus disease 2019 [COVID-19]) binds angiotensin-converting enzyme-2 (ACE-2) receptors to enter the cell. These receptors are widely expressed in the intestine, and COVID-19 may cause gastrointestinal symptoms via these receptors during the course of the disease. Helicobacter pylori is known to increase the expression of ACE-2 receptors in the gastrointestinal tract. The aim of this study was to investigate the effects of H pylori on the presentation and clinical course of COVID-19 infections. METHODS: This study was carried out from June 1 to July 20, 2020. Patients diagnosed with COVID-19 infections by PCR tests were included in the study. Antigen screening tests were performed on stool samples to determine the presence of H pylori. All patients were evaluated for manifestations of COVID-19 infection, severity of the course, hospitalized days because of the virus and outcome of the disease process. RESULTS: Of 108 COVID-19 positive patients evaluated, 31 with a mean age of 49.54 +/- 17.94 years were H pylori-positive (8 girls [25.8%]) and 77 with a mean age of 47.85 +/- 20.51 years; (31 girls [40.3%]) were H pylori-negative. Abdominal pain (19.4% vs 2.6%) and diarrhea (32.3% vs 9.1%) were significantly higher in patients with H pylori than those without (P = 0.007 and P = 0.006, respectively). There was no statistically significant difference between H pylori positivity and the number of hospitalized days, the severity of the course of COVID-19 infection, or the outcome of the disease (P > 0.05). CONCLUSION: Our results revealed that the findings of abdominal pain and diarrhea strongly correlated with the presence of H pylori in COVID-19 patients. Twit Text FOAVip The Effect of Helicobacter pylori on the Presentation and Clinical Course of Coronavirus Disease 2019 Infection ????J Pediatr Gastroenterol Nutr http://www.kidney.de/pget.php?&tw=1&pmid=33306581 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33306581 #FOAvip English Wikipedia <ref>{{Cite pmid|33306581}}</ref> The Effect of Helicobacter pylori on the Presentation and Clinical Course of Coronavirus Disease 2019 Infection #MMPMID33306581 Balamtekin N; Artuk C; Arslan M; Gulsen M J Pediatr Gastroenterol Nutr 2021[Apr]; 72 (4): 511-513 PMID33306581show ga OBJECTIVES: Novel coronavirus 2019 (corona virus disease 2019 [COVID-19]) binds angiotensin-converting enzyme-2 (ACE-2) receptors to enter the cell. These receptors are widely expressed in the intestine, and COVID-19 may cause gastrointestinal symptoms via these receptors during the course of the disease. Helicobacter pylori is known to increase the expression of ACE-2 receptors in the gastrointestinal tract. The aim of this study was to investigate the effects of H pylori on the presentation and clinical course of COVID-19 infections. METHODS: This study was carried out from June 1 to July 20, 2020. Patients diagnosed with COVID-19 infections by PCR tests were included in the study. Antigen screening tests were performed on stool samples to determine the presence of H pylori. All patients were evaluated for manifestations of COVID-19 infection, severity of the course, hospitalized days because of the virus and outcome of the disease process. RESULTS: Of 108 COVID-19 positive patients evaluated, 31 with a mean age of 49.54 +/- 17.94 years were H pylori-positive (8 girls [25.8%]) and 77 with a mean age of 47.85 +/- 20.51 years; (31 girls [40.3%]) were H pylori-negative. Abdominal pain (19.4% vs 2.6%) and diarrhea (32.3% vs 9.1%) were significantly higher in patients with H pylori than those without (P = 0.007 and P = 0.006, respectively). There was no statistically significant difference between H pylori positivity and the number of hospitalized days, the severity of the course of COVID-19 infection, or the outcome of the disease (P > 0.05). CONCLUSION: Our results revealed that the findings of abdominal pain and diarrhea strongly correlated with the presence of H pylori in COVID-19 patients. |*Helicobacter pylori[MESH] |Abdominal Pain/*etiology/microbiology[MESH] |Adult[MESH] |Aged[MESH] |Angiotensin-Converting Enzyme 2/metabolism[MESH] |COVID-19/*complications[MESH] |Diarrhea/*etiology/microbiology[MESH] |Female[MESH] |Helicobacter Infections/*complications/microbiology[MESH] |Hospitalization[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |SARS-CoV-2[MESH]The Effect of Helicobacter pylori on the Presentation and Clinical Cou(epmc).pdf DeepDyve Pubget Overpricing